Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Modal Dan Cadangan
Keuangan
Harga Saham
USD
Aktiva
USD 12.05B
Kas Dan Setara
USD 1.02B
Biaya Penjualan
USD 312.82M
Aset Lancar
USD 2.3B
Kewajiban Lancar
USD 1.28B
UTANG
USD 3.35B
Dividen - Hasil
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
Karyawan
11K
Eps Laba Per Saham
USD 1.41
Modal Dan Cadangan
USD 7.18B
Laba Kotor Pada Penjualan
USD 416.87M
Beban Bunga Utang
USD 22.99M
Pendapatan Bunga
USD 6.3M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 15.86B
Batas Pemasukan
USD 51.82M
Biaya Operasional
USD 603.55M
Laba Operasional
USD 126.14M
Modal Saham Biasa
USD 111.63M
Pe Harga Untuk Laba
36.47
Laba Sebelum Pajak
USD 187.24M
Pendapatan Penjualan
USD 729.68M
Beban Penjualan Dan Administrasi
USD 278.58M
Saham
USD 378.5M
Kreditur Perdagangan
USD 165.74M
Debitur Perdagangan
USD 709.18M
Modal Dan Cadangan
Perubahan
Tanggal
Agilent
USD 7.36B
241M
2026-06
Align Technology
USD 4.23B
83.03M
2026-06
Bio Techne
USD 2.11B
22.92M
2026-06
Bio-Rad Laboratories
USD 7.17B
322.6M
2026-06
Bruker
USD 2.44B
67M
2026-06
Celltrion
KRW 434.82B
1.14B
2026-03
Charles River Laboratories
USD 2.84B
59.06M
2026-06
Cspc Pharmaceutical
CNY 33.18B
71.46M
2025-12
Danaher
USD 52.58B
368M
2026-06
Dentsply International
USD 1.35B
33M
2026-06
Deva Holding AS
TRY 5.79B
604.07M
2023-09
Dianthus Therapeutics
USD 1.17B
29.29M
2026-06
Divis Laboratories Ltd
INR 167.61B
13.48B
2026-03
Edwards Lifesciences
USD 10.62B
290.5M
2026-06
Illumina
USD 2.84B
162M
2026-06
Intuitive Surgical
USD 18.17B
693.9M
2026-06
IQVIA Holdings
USD 6.17B
50M
2026-06
Kangmei Pharma
CNY 7.31B
84.82M
2026-03
Knight Therapeutics
CAD 767.27M
480K
2025-12
Laboratorios Farma
EUR 539.39M
22.74M
2023-12
Laboratory Of America
USD 8.61B
121.8M
2026-06
Malin Corporation
EUR 193.2M
75M
2024-12
Medical Developments International
AUD 54.77M
335K
2025-12
Mesa Laboratories
USD 186.69M
8.22M
2025-12
Mettler Toledo International
USD 12.82M
54.71M
2026-06
Myriad Genetics
USD 303.9M
33.5M
2026-06
Neuren Pharmaceuticals
AUD 338.45M
15.18M
2025-12
OraSure Technologies
USD 317.78M
4.45M
2026-06
Organigram Holdings
CAD 371.81M
2.36M
2026-03
Ovoca Bio
EUR 780K
485K
2025-12
Pacific Biosciences Of California
USD -33.21M
35.58M
2026-06
Pharma Mar
EUR 250.77M
1.1M
2026-06
Qiagen NV
USD 3.36B
26.03M
2026-06
Quest Diagnostics
USD 7.52B
150M
2026-06
Quidel
USD 1.85B
69.1M
2026-03
Repligen
USD 2.11B
6.57M
2026-06
Revvity
USD 7.18B
67.62M
2026-03
Sartorius
EUR 2.82B
96.3M
2026-06
Sino Biopharmaceutical
CNY 34B
1.48B
2025-06
Thermo Fisher Scientific
USD 51.93B
1.6B
2026-03
Tilray
USD 1.58B
39.08M
2025-09
Waters
USD 15.29B
12.73B
2026-03
Zealand Pharma A/S
14.47B
361.61M
2026-03
Zz Pientze Pharmaceu
CNY 15.21B
740.32M
2026-03
×